1-149929140-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001145862.2(MTMR11):c.2119G>T(p.Asp707Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000434 in 1,611,576 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001145862.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MTMR11 | NM_001145862.2 | c.2119G>T | p.Asp707Tyr | missense_variant | 17/17 | ENST00000439741.4 | NP_001139334.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MTMR11 | ENST00000439741.4 | c.2119G>T | p.Asp707Tyr | missense_variant | 17/17 | 2 | NM_001145862.2 | ENSP00000391668.2 |
Frequencies
GnomAD3 genomes AF: 0.0000989 AC: 15AN: 151726Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000399 AC: 10AN: 250372Hom.: 0 AF XY: 0.0000369 AC XY: 5AN XY: 135338
GnomAD4 exome AF: 0.0000377 AC: 55AN: 1459850Hom.: 0 Cov.: 34 AF XY: 0.0000455 AC XY: 33AN XY: 726022
GnomAD4 genome AF: 0.0000989 AC: 15AN: 151726Hom.: 0 Cov.: 31 AF XY: 0.0000811 AC XY: 6AN XY: 74024
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 06, 2023 | The c.2119G>T (p.D707Y) alteration is located in exon 17 (coding exon 17) of the MTMR11 gene. This alteration results from a G to T substitution at nucleotide position 2119, causing the aspartic acid (D) at amino acid position 707 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at